Dr. Anvesh Dharanikota – Surgical Oncologist
Dr. Anvesh Dharanikota is a renowned Surgical Oncologist affiliated with Medicover Cancer Institute in Hitech City. With 12 years of experience, he has served as an expert Surgical Oncologist in various cities across India. His extensive career includes managing numerous complex medical cases at several hospitals. Dr. Dharanikota is highly regarded for his precise diagnostic skills and effective treatment strategies. He has compassionate approach towards patient care. His dedication to oncology has made significant impacts on patient outcomes.
Specializations
Dr. Anvesh Dharanikota performs major interventions in the following specialities –
- Surgical Oncology
Expertise
Dr Anvesh Dharanikota has gained expertise in the following major interventions –
- GI & Thoracic Oncology
- Breast Oncoplastic Surgery
- Gynaecological Oncology
- Musculoskeletal Oncology
Education & Achievements
- Dr NTR University of Health Sciences, Andhra Pradesh (MBBS)
- MS General Surgery
- MCh Surgical Oncology
- FAIS
- FALS
Work Experience
- June 2022 to November 2023 – Consultant Surgical Oncologist at Basavatarakam Indo-American Cancer Hospital & Research Institute, Hyderabad.
- August 2021 to May 2022 – Consultant Surgical Oncologist at Dharani Multispecialty Hospital, Miryalguda.
- August 2018 to August 2021 – Resident, Department of Surgical Oncology at Kidwai Memorial Institute of Oncology, Bangalore.
- June 2018 to July 2018 – Assistant Professor, Department of General Surgery at Bhaskar Medical College, Hyderabad.
- April 2018 to May 2018 – Senior Resident, Department of General Surgery at Bhaskar Medical College, Hyderabad.
- December 2016 to December 2017 – Senior Resident, Department of Surgical Oncology at MNJ Institute of Oncology & Regional Cancer Center, Hyderabad.
- July 2013 to July 2016 – Resident, Department of General Surgery at Katuri Medical College & Hospital, Guntur.
Awards & Recognitions
- GOLD MEDAL awarded for securing highest number of marks in the Post Graduate examinations held in 2016.
- BEST PRESENTATION AWARD for oral presentation on “The impact of robotic assisted minimally invasive esophagectomy on postoperative pulmonary complications – A prospective analysis” in International Conference held at Nagoya, Japan (ACRLS 2022).
- BEST POSTER AWARD for presentation at National Conference held at Tirupati, Andhra Pradesh (MIDCON 2020).
- BEST POSTER AWARD for presentation at National Conference held at Gurgaon, New Delhi (ASICON 2015).
Memberships
- Indian Academy of Oral and Maxillofacial Surgeons (IAOMS)
- International Federation of Head Neck Oncology (IFHCO)
Publications
Dr Anvesh Dharanikota has authored several publications including –
- Current status of indocyanine green fluorescent angiography in assessing perfusion of gastric conduit and esophago-gastric anastomosis
- Current status of indocyanine green fluorescent angiography in assessing perfusion of gastric conduit and esophago-gastric anastomosis
- 47P Sequencing of chemotherapy and surgery among older triple-negative and HER2-positive breast cancer patients with comorbidities
- 45P Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
- Impact of Level of Surgery on the Functional Outcomes in Patients with Lower Extremity Bone Tumors Undergoing Amputation Versus Limb Salvage Surgery
- Operative Outcomes of Minimally Invasive Esophagectomy versus Open Esophagectomy for Resectable Esophageal Cancer
- Factors Affecting Prognosis and Survival in Extremity Osteosarcoma
- Survival Outcomes in Patients with Thymoma after Thymectomy in an Indian Scenario
- Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis
- A RARE CASE OF INDIRECT INGUINAL HERNIA WITH OVARY AS CONTENT
- A CLINICAL STUDY TO ANALYSE THE SPECTRUM OF PERITONITIS DUE TO HOLLOW VISCUS PERFORATION
Treatments
Dr. Anvesh Dharanikota specializes in the following treatments –
Languages
- English
- Telugu
- Hindi
Dr. Dharanikota’s expertise spans across diverse and challenging surgical oncology procedures. His contributions to the field have been recognized and appreciated by both colleagues and patients. He continues to be a key figure in advancing cancer treatment and care at Medicover Cancer Institute.